Emdeon Announces Billing Solution for H1N1 Vaccine Administration
2009年11月4日 - 10:30PM
PRニュース・ワイアー (英語)
Electronic alternative to paper billing helps to connect retail
pharmacies with the nation's top 25 medical payers in real-time
NASHVILLE, Tenn., Nov. 4 /PRNewswire-FirstCall/ -- Emdeon®
(NYSE:EM), a leading provider of healthcare revenue and payment
cycle management solutions, today announced that its eRx Network®
will provide real-time electronic billing solutions to retail
pharmacies for the nation's top 25 medical payers in light of the
dramatic increase in H1N1 vaccinations being administered by
pharmacies. The Center for Disease Control and Prevention predicts
10-12 million doses of the H1N1 vaccination will be available by
the end of October and many of these vaccinations will be
administered by retail pharmacies. Retail pharmacies and other mass
vaccination organizations often lack the ability to bill medical
claims electronically and thus submit claims on paper to the paying
health plan. While the vaccine itself is provided at no charge,
administration of the H1N1 vaccine is a medical procedure
reimbursable under the medical benefits of many health plans. "This
is the first time in many years that the healthcare industry has
faced a real-world pandemic and we are able to rise to that need
with a real-time, electronic solution that will help pharmacies
process medical claims efficiently," said Mark Lyle, senior vice
president for eRx Network pharmacy services at Emdeon. The Emdeon
eRx Network solution enables both new and existing retail pharmacy
customers to submit these medical services for reimbursement to
health plans in a standard electronic pharmacy claim. The medical
claim will then be delivered to the payer and processed through
their standard reimbursement cycle. Ultimately, Emdeon will help to
facilitate the claim processing and the health plan will
potentially avoid expensive, manual workload associated with paper
claim submission. "By providing the marketplace with innovative
solutions, Emdeon continues to demonstrate the value of having one
partner in the healthcare industry to address market
opportunities," said George Lazenby, chief executive officer of
Emdeon. "This timely solution is an example of combining Emdeon's
broad connectivity in both the pharmacy and payer markets to
simplify the business of healthcare," Lazenby continued. In
addition to the solutions being provided to eRx Network customers,
other Emdeon customers that utilize Emdeon Office(TM), a
multi-payer portal for healthcare revenue cycle management, also
are able to process claims for H1N1 vaccination administration
electronically. Emdeon Office allows these providers to verify
insurance eligibility for more than 500 payers nationally, submit
and track claims, and manage any changes to those claims through a
web-based interface. About Emdeon® Emdeon (NYSE:EM) is a leading
provider of revenue and payment cycle management solutions,
connecting payers, providers and patients in the U.S. healthcare
system. Emdeon's product and service offerings integrate and
automate key business and administrative functions of its payer and
provider customers throughout the patient encounter. Through the
use of Emdeon's comprehensive suite of products and services, which
are designed to easily integrate with existing technology
infrastructures, customers are able to improve efficiency, reduce
costs, increase cash flow and more efficiently manage the complex
revenue and payment cycle process. For more information, visit
http://www.emdeon.com/. Statements made in this press release that
express Emdeon's or management's intentions, plans, beliefs,
expectations or predictions of future events are forward-looking
statements, which Emdeon intends to be covered by the safe harbor
provisions for forward-looking statements contained in the Private
Securities Litigation Reform Act of 1995. These statements often
include words such as "may," "will," "should," "believe," "expect,"
"anticipate," "intend," "plan," "estimate" or similar expressions.
Forward-looking statements may include information concerning
Emdeon's possible or assumed future results of operations,
including descriptions of Emdeon's revenues, profitability and
outlook for 2009 and its overall business strategy. You should not
place undue reliance on these statements because they are subject
to numerous uncertainties and factors relating to Emdeon's
operations and business environment, all of which are difficult to
predict and many of which are beyond Emdeon's control. Although
Emdeon believes that these forward-looking statements are based on
reasonable assumptions, you should be aware that many factors could
affect Emdeon's actual financial results or results of operations
and could cause actual results to differ materially from those in
the forward-looking statements, including the risks discussed in
the "Risk Factors" and "Management's Discussion and Analysis of
Financial Condition and Results of Operations" sections and
elsewhere in Emdeon's Registration Statement on Form S-1 and the
accompanying Prospectus thereto, as filed with the SEC, as well as
Emdeon's periodic reports filed with the SEC and other public
filings of Emdeon. You should keep in mind that any forward-looking
statement made by Emdeon herein, or elsewhere, speaks only as of
the date on which made. Emdeon expressly disclaims any intent,
obligation or undertaking to update or revise any forward-looking
statements made herein to reflect any change in Emdeon's
expectations with regard thereto or any change in events,
conditions or circumstances on which any such statements are based.
DATASOURCE: Emdeon CONTACT: Amanda Woodhead, media contact of
Emdeon, +1-615-932-3863, , or Tommy Lewis, Investor Relations
Contact of Emdeon, +1-615-932-3235, Web Site:
http://www.emdeon.com/
Copyright